{
    "Trade/Device Name(s)": [
        "OneTouch Ultra Plus Flex Blood Glucose Monitoring System",
        "OneTouch Ultra Plus Flex Blood Glucose Meter",
        "OneTouch Ultra Plus Test Strips",
        "OneTouch Ultra Plus Level 3 Control Solution",
        "OneTouch Ultra Plus Level 4 Control Solution",
        "Lancing Device",
        "Sterile Lancets"
    ],
    "Submitter Information": "LifeScan Europe, a Division of Cilag GmbH International",
    "510(k) Number": "K151611",
    "Predicate Device Reference 510(k) Number(s)": [
        "K131363"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "November 17, 2015",
    "Summary Letter Received Date": "November 20, 2015",
    "Submission Date": "December 11, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "OneTouch Ultra Plus Flex Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical reaction",
        "Amperometric detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strips",
        "Control Solution",
        "Lancing Device",
        "Lancets"
    ],
    "Document Summary": "FDA 510(k) summary for OneTouch Ultra Plus Flex Blood Glucose Monitoring System for self-monitoring of blood glucose by diabetic patients using electrochemical detection.",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from the fingertip for self-testing by people with diabetes at home as an aid to monitor diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}